Sector consensus Beam Therapeutics Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 12/06/2026 BST			5-day change	1st Jan Change
29.03 ^USD	-1.29%		-1.26%	+4.73%

05-25	Beam Therapeutics Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-20-2026 10:30 AM
05-18	Beam Therapeutics Inc. Presents Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency At American Thoracic Society International Conference	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
BEAM THERAPEUTICS INC.	51.07	+75.91%	15
LONZA GROUP AG	663.52	+35.33%	23
REVOLUTION MEDICINES, INC.	187.29	+21.72%	21
IQVIA HOLDINGS INC.	226.95	+25.07%	19
BEONE MEDICINES AG	412.35	+55.91%	27
CELLTRION, INC.	252,919.41	+46.2%	24
MEDPACE HOLDINGS, INC.	442.83	-5.24%	12
EUROFINS SCIENTIFIC SE	70.89	+10.62%	14
IONIS PHARMACEUTICALS, INC.	102.17	+39.43%	24
ICON PUBLIC LIMITED COMPANY	153.25	+4.84%	16
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	212.27	+13.2%	15
TEMPUS AI, INC.	66.53	+39.13%	15
BIO-TECHNE CORPORATION	61.69	+14.24%	13
ABIVAX	115.77	+36.12%	7
QIAGEN N.V.	43.82	+18.24%	14
PRAXIS PRECISION MEDICINES, INC.	627.59	+135.42%	17
ALKERMES PLC	46.12	+4.17%	16
KYMERA THERAPEUTICS, INC.	119.43	+38.54%	21
Average	14,251.27	+33.82%	17
Weighted average by Cap.	23,209.48	+32.26%	20